Research Article
Low-Content Quantitation in Entecavir Tablets Using 1064 nm Raman Spectroscopy
Table 4
The actual and predicted API content and the percentage of predicted API in the drug content calculated by the best performance model.
| Test set sample | Acceptance API content | Predicted API content (mg) |
| Baraclude 0.5 mg (90%–105%) | 0.45–0.53 mg | 0.47 | Baraclude 0.5 mg (90%–105%) | 0.45–0.53 mg | 0.45 | Baraclude 1.0 mg (90%–105%) | 0.9–1.05 mg | 0.93 | Baraclude 1.0 mg (90%–105%) | 0.9–1.05 mg | 0.91 | 0.5% (w/w%) | 0.5% | 0.55 | 0.5% (w/w%) | 0.5% | 0.50 |
|
|